Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
MUMBAI, INDIA— May 15, 2013 — India’s initiatives to encourage the enforcement of regulations will be discussed by prominent industry experts at DIA India’s 6th Regulatory Conference, to be held in a week’s time in Ahmedabad, Gujarat.
The two-day event, from May 23-24, will bring together local and multinational pharmaceutical companies, clinical research professionals, academicians, regulators, and key stakeholders in health authorities to share the knowledge they’ve gained from decades of experience and note-worthy contributions to the development of the Indian pharmaceutical industry.
The conference will feature Rajiv Gulati, President Global Pharmaceuticals Business, Ranbaxy Laboratories Limited, speaking on the theme “India, the Upcoming Economy: Encouraging Enforcement of Regulations.” Also participating will be the Drug Controller General of India (DCGI), Dr. G. N. Singh.
To find out more about the event, or to register, visit www.diahome.org/India6thRegulatory.
DIA is a neutral, global, professional, member-driven association of nearly 18,000 professionals involved in the discovery, development, and life cycle management of pharmaceuticals, biotechnology, medical devices and related health care products. Through our international educational offerings and myriad networking opportunities, DIA provides a global forum for knowledge exchange that fosters the innovation of products, technologies and services to improve health and well being worldwide. Headquarters are in Horsham, Pa., USA, with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India and Beijing, China. www.diahome.org
To request a press pass email Eric.Rosen@diahome.org
Help employers find you! Check out all the jobs and post your resume.